Related News

View All News

Press Releases

Corporate Ventures Fund of Merck KGaA, Darmstadt, Germany, Creates New Immuno ...

Darmstadt, Germany, June 20, 2016 – Merck KGaA, Darmstadt, Germany today announced its corporate venture arm created iOnctura SA, Geneva, Switzerland.

2017/06/20

Press Releases

Merck KGaA, Darmstadt, Germany Divests Biosimilars Business to Fresenius

Darmstadt, Germany, April 24, 2017 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the divestment of its Biosimilars business to Fresenius. The decision to divest Bio

2017/04/24

Press Releases

FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved ...

Darmstadt, Germany, and New York, US, March 23, 2017 – Merck KGaA, Darmstadt, Germany and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelum...

2017/03/23

Upcoming Event

View All Events

Share Price

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price
Capital Market Days
Learn More
Capital Market Days

At our Capital Market Days, our shareholders have the opportunity to meet our management and gain insights into our success story. We inform investors about our strategy, the latest financial developments and about our plans for the future.

Webcasts & Presentations
Learn More
Webcasts & Presentations

There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.

Annual General Meeting
Learn More
Annual General Meeting

Every year, our shareholders come together to make important decisions on our company’s business. We provide comprehensive material to help them make well-informed voting decisions.

RSS Feeds

Open one of the following links in a RSS feeder of your choice:

Get in touch!

We're here to help. Get in touch if you have any questions.